Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
25.35
-1.77 (-6.53%)
At close: Aug 25, 2025, 4:00 PM
25.44
+0.09 (0.36%)
After-hours: Aug 25, 2025, 4:41 PM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $9.86 billion as of August 25, 2025. Its market cap has decreased by -68.54% in one year.
Market Cap
9.86B
Enterprise Value
3.33B
1-Year Change
-68.54%
Ranking
Category
Stock Price
$25.35
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $9.86B, an increase of 61.20%. That is a compound annual growth rate of 7.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 10.55B | -34.05% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | 41.34B | 534.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 626.32B |
| Johnson & Johnson | 430.83B |
| AbbVie | 367.11B |
| UnitedHealth Group | 276.32B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 231.01B |